Stock Scorecard
Stock Summary for Nano X Imaging Ltd (NNOX) - $3.86 as of 12/3/2025 8:37:26 PM EST
Total Score
10 out of 30
Safety Score
25 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for NNOX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NNOX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NNOX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NNOX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for NNOX (25 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 5 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for NNOX
Financial Details for NNOX
Company Overview |
|
|---|---|
| Ticker | NNOX |
| Company Name | Nano X Imaging Ltd |
| Country | USA |
| Description | Nano-X Imaging Ltd. (NNOX) is revolutionizing the medical imaging industry through its innovative digital X-ray source technology, aimed at making imaging more cost-effective and widely accessible. Headquartered in Neve Ilan, Israel, the company is poised to challenge traditional imaging solutions and drive substantial advancements in healthcare delivery. As a development-stage firm, Nano-X's commitment to enhancing diagnostic capabilities positions it as a key player in the evolution of medical technology, with the potential to significantly improve patient outcomes globally. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 3.86 |
| Price 4 Years Ago | 14.54 |
| Last Day Price Updated | 12/3/2025 8:37:26 PM EST |
| Last Day Volume | 1,863,487 |
| Average Daily Volume | 2,030,753 |
| 52-Week High | 11.00 |
| 52-Week Low | 2.78 |
| Last Price to 52 Week Low | 38.85% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 45.50 |
| Sector PE | 88.06 |
| 5-Year Average PE | -7.67 |
| Free Cash Flow Ratio | 5.59 |
| Industry Free Cash Flow Ratio | 27.49 |
| Sector Free Cash Flow Ratio | 28.78 |
| Current Ratio Most Recent Quarter | 4.14 |
| Total Cash Per Share | 0.69 |
| Book Value Per Share Most Recent Quarter | 2.40 |
| Price to Book Ratio | 1.87 |
| Industry Price to Book Ratio | 4.38 |
| Sector Price to Book Ratio | 33.12 |
| Price to Sales Ratio Twelve Trailing Months | 23.81 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.92 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.97 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 65,383,000 |
| Market Capitalization | 252,378,380 |
| Institutional Ownership | 19.48% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 11.95% |
| Reported EPS 12 Trailing Months | -0.88 |
| Reported EPS Past Year | -0.55 |
| Reported EPS Prior Year | -0.76 |
| Net Income Twelve Trailing Months | -55,706,000 |
| Net Income Past Year | -53,516,000 |
| Net Income Prior Year | -60,776,000 |
| Quarterly Revenue Growth YOY | 13.70% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | -413.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 45,186,000 |
| Total Cash Past Year | 39,304,000 |
| Total Cash Prior Year | 56,377,000 |
| Net Cash Position Most Recent Quarter | 41,840,000 |
| Net Cash Position Past Year | 35,823,000 |
| Long Term Debt Past Year | 3,481,000 |
| Long Term Debt Prior Year | 3,481,000 |
| Total Debt Most Recent Quarter | 3,346,000 |
| Equity to Debt Ratio Past Year | 0.98 |
| Equity to Debt Ratio Most Recent Quarter | 0.98 |
| Total Stockholder Equity Past Year | 189,119,000 |
| Total Stockholder Equity Prior Year | 195,514,000 |
| Total Stockholder Equity Most Recent Quarter | 156,709,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -46,702,719 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.71 |
| Free Cash Flow Past Year | -39,365,000 |
| Free Cash Flow Prior Year | -48,080,000 |
Options |
|
| Put/Call Ratio | 0.04 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.17 |
| MACD Signal | -0.01 |
| 20-Day Bollinger Lower Band | 3.02 |
| 20-Day Bollinger Middle Band | 4.02 |
| 20-Day Bollinger Upper Band | 5.03 |
| Beta | 1.08 |
| RSI | 63.79 |
| 50-Day SMA | 5.25 |
| 150-Day SMA | 7.49 |
| 200-Day SMA | 8.35 |
System |
|
| Modified | 12/2/2025 5:06:27 AM EST |